Catalio Capital Management, LP Q4 2025 Filing
Filed February 17, 2026
Portfolio Value
$565.8M
Holdings
45
Report Date
Q4 2025
Filing Type
13F-HR
All Holdings (45 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | GILDGILEAD SCIENCES INC | 289,312 | $35.5M | 6.28% | |
| 2 | BMYBRISTOL-MYERS SQUIBB CO | 647,899 | $34.9M | 6.18% | |
| 3 | BSXBOSTON SCIENTIFIC CORP | 360,428 | $34.4M | 6.07% | |
| 4 | BBOTBRIDGEBIO ONCOLOGY THERAPEUT | 410,700 | $31.4M | 5.55% | |
| 5 | LLYELI LILLY & CO | 25,923 | $27.9M | 4.92% | |
| 6 | DNTHDIANTHUS THERAPEUTICS INC | 653,572 | $26.9M | 4.76% | |
| 7 | ASNDASCENDIS PHARMA A/S | 119,265 | $25.4M | 4.49% | |
| 8 | SNDXSYNDAX PHARMACEUTICALS INC | 1,196,807 | $25.1M | 4.44% | |
| 9 | JNJJOHNSON & JOHNSON | 120,840 | $25.0M | 4.42% | |
| 10 | REGNREGENERON PHARMACEUTICALS | 29,797 | $23.0M | 4.06% | |
| 11 | GPCRSTRUCTURE THERAPEUTICS INC | 252,901 | $17.6M | 3.11% | |
| 12 | SLNOSOLENO THERAPEUTICS INC | 360,340 | $16.7M | 2.95% | |
| 13 | CYTKCYTOKINETICS INC | 258,381 | $16.4M | 2.90% | |
| 14 | EWEDWARDS LIFESCIENCES CORP | 187,048 | $15.9M | 2.82% | |
| 15 | ISRGINTUITIVE SURGICAL INC | 27,209 | $15.4M | 2.72% | |
| 16 | NTRANATERA INC | 62,273 | $14.3M | 2.52% | |
| 17 | ADPTADAPTIVE BIOTECHNOLOGIES COR | 821,195 | $13.3M | 2.36% | |
| 18 | ABVXABIVAX SA | 98,514 | $13.3M | 2.35% | |
| 19 | SUPNSUPERNUS PHARMACEUTICALS INC | 257,465 | $12.8M | 2.26% | |
| 20 | GUTSFRACTYL HEALTH INC | 5,491,866 | $12.1M | 2.14% | |
| 21 | MLYSMINERALYS THERAPEUTICS INC | 331,849 | $12.0M | 2.13% | |
| 22 | PHATPHATHOM PHARMACEUTICALS INC | 698,996 | $11.6M | 2.05% | |
| 23 | ADMAADMA BIOLOGICS INC | 564,461 | $10.3M | 1.82% | |
| 24 | ACLXARCELLX INC | 156,109 | $10.2M | 1.80% | |
| 25 | DYNDYNE THERAPEUTICS INC | 519,715 | $10.2M | 1.80% | |
| 26 | IRONDISC MEDICINE INC | 110,427 | $8.8M | 1.55% | |
| 27 | OCULOCULAR THERAPEUTIX INC | 714,501 | $8.7M | 1.53% | |
| 28 | SEPNSEPTERNA INC | 294,360 | $8.2M | 1.45% | |
| 29 | TARAPROTARA THERAPEUTICS INC | 1,446,254 | $7.7M | 1.36% | |
| 30 | QUREUNIQURE NV | 288,345 | $6.9M | 1.22% | |
| 31 | OLMAOLEMA PHARMACEUTICALS INC | 267,058 | $6.7M | 1.18% | |
| 32 | TERNTERNS PHARMACEUTICALS INC | 136,958 | $5.5M | 0.98% | |
| 33 | RAREULTRAGENYX PHARMACEUTICAL IN | 162,550 | $3.7M | 0.66% | |
| 34 | HTFLHEARTFLOW INC | 113,857 | $3.3M | 0.59% | |
| 35 | GRALGRAIL INC | 30,313 | $2.6M | 0.46% | |
| 36 | FULCFULCRUM THERAPEUTICS INC | 201,301 | $2.3M | 0.40% | |
| 37 | BLLNBILLIONTOONE INC | 25,505 | $2.1M | 0.37% | |
| 38 | ELDNELEDON PHARMACEUTICALS INC | 1,259,820 | $1.9M | 0.34% | |
| 39 | HYPRHYPERFINE INC | 1,320,041 | $1.3M | 0.23% | |
| 40 | PVLAPALVELLA THERAPEUTICS INC NE | 10,452 | $1.1M | 0.19% | |
| 41 | KPTIKARYOPHARM THERAPEUTICS INC | 142,984 | $1.1M | 0.19% | |
| 42 | MGXMETAGENOMI INC | 528,993 | $856K | 0.15% | |
| 43 | ATAIATAI BECKLEY NV | 196,858 | $805K | 0.14% | |
| 44 | OMOUTSET MED INC | 118,279 | $438K | 0.08% | |
| 45 | SNSESENSEI BIOTHERAPEUTICS INC | 14,718 | $157K | 0.03% |